List of Eligard Kit drug patents

Eligard Kit is owned by Tolmar Therap.

Eligard Kit contains Leuprolide Acetate.

Eligard Kit has a total of 1 drug patent out of which 0 drug patents have expired.

Eligard Kit was authorised for market use on 24 July, 2002.

Eligard Kit is available in powder;subcutaneous dosage forms.

Eligard Kit can be used as method of treating cancer.

The generics of Eligard Kit are possible to be released after 15 October, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8470359 TOLMAR THERAP Sustained release polymer
Oct, 2023

(8 months from now)

Drugs and Companies using LEUPROLIDE ACETATE ingredient

Market Authorisation Date: 24 July, 2002

Treatment: Method of treating cancer

Dosage: POWDER;SUBCUTANEOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in